Intended for use with payers, formulary committees, or other similar entities for purposes of population-based drug selection, coverage, and/or reimbursement decision making, pursuant to FD&C Act Section 502(a).

Partnering Together: To Help You Navigate the Future of Chronic Kidney Disease

For all appropriate patients:

Potentially eliminate or reduce the cost of dialysis¹

Reduce costs for the capitated population¹

Improve care
coordination²

Raise awareness about living kidney donation²

Put your patients with Chronic Kidney Disease on the Path to a Pre-Dialysis Transplant

Increasing access to pre-dialysis transplants may
benefit you and your beneficiaries^1,3

Kidney Failure

Annually there are
~136,000 patients diagnosed with kidney failure^3,*

Dialysis

Most of these patients will follow a path that leads them to dialysis^3,*

Kidney Transplant

Only ~3% (4,153) of patients will receive preemptive kidney transplant (PKT), the therapy recommended by Kidney Disease Improving Global Outcomes (KDIGO)^3,4,*

For all appropriate patients:

Potentially Eliminate or Reduce Your Medical Spend for Dialysis^1,3

Commercial insurance reimburses for dialysis at a higher rate than Medicare⁷

PKT offers significant cost savings vs non-PKT with commercial insurance^8,¶

Raise Awareness About Living Donation^9,10

Identify, educate, and refer transplant eligible patients

Early kidney disease education (KDE) (eg, at chronic kidney disease [CKD] stage 4) can lead to an increased use of living donor PKT^9,#

of kidney transplant candidates underwent a living donor kidney transplant with early education^9,#

of patients wait-listed before dialysis received a living donor kidney transplant 3 years after the preemptive listing¹⁰

Improve Fragmented Care^3,10-13

Identifying and educating patients with CKD earlier can improve care and reduce barriers to transplant.¹¹
Calculate your patient's Estimated Post Transplant Score (EPTS) to identify recipients who may benefit most from rapid waiting list placement and transplantation.¹⁰

Candidates are less likely to lose their top-tier EPTS status when they are preemptively wait-listed.¹⁰

From 2015-2017, only 1 in 5 kidney transplant candidates with top-tier EPTS scores were preemptively wait-listed for transplant.¹⁰

Candidates with a top 20% EPTS status have preferential access to deceased donor kidney offers with the lowest cumulative risk factors.¹⁰

Only 37% of patients with top 20% ETPS status were added to the waiting list within 3 years of dialysis initiation.¹⁰

Use of the Centers for Medicare and Medicaid (CMS) KDE benefit can help increase your PKT population¹²

In 2018, only ~1% of eligible patients with CKD stage 4 had a claim for kidney disease education¹³

Utilization of the CMS KDE benefit resulted in:

increase in pre-ESRD wait-listing^12,††

increase in PKT^12,††

Improve Health Outcomes^3,14

With a living donor (LD), your kidney transplant candidates may achieve:

lower rates of delayed graft
function vs non-PKT^14,††

increase in 5-year survival vs hemodialysis^3,§§

Stay Up-to-Date with Professional Guidelines¹⁵

Educate at CKD stage 3, refer at CKD stage 4, and transplant at CKD stage 5^15,¶¶

The following guidelines assist health care professionals in the field of kidney transplantation to evaluate and manage care for their patients

To learn more, click on the individual guidelines.Read KDIGO Guidelines

Read Organ Procurement and Transplantation Network (OPTN) Guidance

The Advancing American Kidney Health (AAKH) Initiative aims to double the number of kidneys available for transplant by 2030, through strategies such as increasing available options for individuals in need of kidney transplants and access to PKT.²

Resources to Support Your Appropriate Patients on the Journey to LD PKT

Bring the experts in kidney transplant education to your patients! Click on each resource to learn more.

EXPLORE Transplant: Meet with EXPLORE Transplant, an evidence-based education platform to coach patients and potential donors through the transplant decision process. Patients can also record their own stories to create awareness and address the living donor shortage.

Rejuvenate: Meet with Rejuvenate Kidney Transplant Solutions, which offers a full range of transplant solutions to increase earlier access to care, locate donors, and reduce health care spend.

CMS Kidney Disease Education Benefit: Offer the CMS Kidney Disease Education benefit to your patients with CKD stage 4 or 5.

Kidney Failure Risk Equation: Know your patient’s estimated time to kidney failure using predictive analytics.

EPTS Calculator: Calculate your patient’s EPTS score to identify candidates with the longest expected posttransplant survival.

American Society of Transplantation (AST) Living Donor Toolkit: Help potential living donors make an informed decision about donation.

learn about pkt and the benefits of
kidney transplant

Download Sanofi’s Transplant Opportunity Brochure

Learn more about some of the staggering disparities faced by those in need of kidney transplant.

Download

Disparities Appear Throughout the Kidney Transplant Patient Journey

Download

Disparities in Kidney Transplantation

View Transcript

Disparities in Kidney Transplantation

In 2018, 87% of patients living in the US with end-stage renal disease were non-White¹

Despite this, White patients where twice as likely to be added to the waitlist¹

In 2019, 66% of all patients on the kidney transpalnt waitlist were non-White

underrepresented minorities were less likely to receive a transplant vs White patients despite greater end-stage renal disease prevalence ¹

In 2020, althought deceased donor kidney transplant rates were equivalent among non-White and White recipients, living donor kidney transplant rates differed by race/ethnicity³

Compared with White recipients, Black recipients were ~6X less likely to receive a living donor kidney transplant³

hispanic recipients were ~4X less likely to receive a living donor kidney transplant³

Transpalnt By the Numbers Sanofi is committed to partnering with the transplant community in recognizing and addressing issues that may contribute to disparities in transplantation and driving equity in health care through the education of patients and providers.